Form 4 for KALA KALA BIO, Inc.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-11 · accession 0001415889-24-016570 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-12 | 2024-06-11 | KALA | KOVEN ANDREW I | Dir | A - Grant | $0.00 | +1,750 | 13.9K | +14% | $0 |
| D | 2024-06-12 | 2024-06-11 | KALA | KOVEN ANDREW I | Dir | A - Grant | $0.00 | +3,900 | 3,900 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-11 | A | A | 1,750 | $0.00 | 13,922 | D | — | — | (F1) Grant of restricted stock units ("RSUs") under the Issuer's Amended and Restated 2017 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the reporting person's continued service, the RSUs will vest as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024. (F2) Includes 10,864 unvested RSUs. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-11 | A | A | 3,900 | $0.00 | 3,900 | D | $6.18 · — to 2034-06-10 | 3,900 Common Stock | (F3) This option was granted on June 11, 2024 and vests as to 100% of the shares underlying the grant on the earlier of (i) June 11, 2025 or (ii) the date of the first annual meeting following June 11, 2024. |